|
US527565A
(en)
*
|
|
1894-10-16 |
|
tripp |
|
US3034507A
(en)
|
1960-05-10 |
1962-05-15 |
American Cyanamid Co |
Intracutaneous injection device
|
|
US3539465A
(en)
|
1968-10-08 |
1970-11-10 |
Ncr Co |
Encapsulation of hydrophilic liquid-in-oil emulsions
|
|
US3675766A
(en)
|
1970-02-04 |
1972-07-11 |
Sol Roy Rosenthal |
Multiple puncture injector device
|
|
US4897355A
(en)
|
1985-01-07 |
1990-01-30 |
Syntex (U.S.A.) Inc. |
N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
|
IE61148B1
(en)
*
|
1988-03-10 |
1994-10-05 |
Ici Plc |
Method of detecting nucleotide sequences
|
|
US5674844A
(en)
|
1991-03-11 |
1997-10-07 |
Creative Biomolecules, Inc. |
Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
|
|
US6506729B1
(en)
|
1991-03-11 |
2003-01-14 |
Curis, Inc. |
Methods and compositions for the treatment and prevention of Parkinson's disease
|
|
US5656593A
(en)
|
1991-03-11 |
1997-08-12 |
Creative Biomolecules, Inc. |
Morphogen induced periodontal tissue regeneration
|
|
US6949505B1
(en)
|
1991-03-11 |
2005-09-27 |
Curis, Inc. |
Morphogen-induced dendritic growth
|
|
US5849686A
(en)
|
1991-03-11 |
1998-12-15 |
Creative Biomolecules, Inc. |
Morphogen-induced liver regeneration
|
|
US6800603B2
(en)
|
1991-03-11 |
2004-10-05 |
Curis, Inc. |
Morphogen-induced neural cell adhesion
|
|
US5993434A
(en)
|
1993-04-01 |
1999-11-30 |
Genetronics, Inc. |
Method of treatment using electroporation mediated delivery of drugs and genes
|
|
US5843780A
(en)
|
1995-01-20 |
1998-12-01 |
Wisconsin Alumni Research Foundation |
Primate embryonic stem cells
|
|
US5711964A
(en)
|
1995-06-07 |
1998-01-27 |
United States Of America |
Method for the intracellular delivery of biomolecules using liposomes containing cationic lipids and vitamin D
|
|
ATE493141T1
(de)
|
1996-03-22 |
2011-01-15 |
Stryker Corp |
Verfahren zur verbesserten funktionellen erholung der motorischen koordiination, der sprache oder der sinneswahrnehmung nach trauma oder ischämie des zns
|
|
US6498142B1
(en)
|
1996-05-06 |
2002-12-24 |
Curis, Inc. |
Morphogen treatment for chronic renal failure
|
|
US6602693B1
(en)
|
1996-07-03 |
2003-08-05 |
Clear Solutions Biotech, Inc. |
Gene encoding hyaluronan synthase
|
|
EP0955999B1
(en)
|
1996-08-19 |
2001-12-05 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Novel liposome complexes for increased systemic delivery
|
|
US6770291B2
(en)
|
1996-08-30 |
2004-08-03 |
The United States Of America As Represented By The Department Of Health And Human Services |
Liposome complexes for increased systemic delivery
|
|
TW520297B
(en)
|
1996-10-11 |
2003-02-11 |
Sequus Pharm Inc |
Fusogenic liposome composition and method
|
|
US6653104B2
(en)
|
1996-10-17 |
2003-11-25 |
Immunomedics, Inc. |
Immunotoxins, comprising an internalizing antibody, directed against malignant and normal cells
|
|
JP2001508302A
(ja)
|
1997-01-10 |
2001-06-26 |
ライフ テクノロジーズ，インコーポレイテッド |
胚性幹細胞血清置換
|
|
US6316260B1
(en)
|
1997-08-22 |
2001-11-13 |
Bernina Biosystems Gmbh |
Tetraether lipid derivatives and liposomes and lipid agglomerates containing tetraether lipid derivatives, and use thereof
|
|
EP1021549A2
(en)
|
1997-09-19 |
2000-07-26 |
Sequitur, Inc. |
SENSE mRNA THERAPY
|
|
CA2350882C
(en)
|
1998-11-12 |
2011-02-22 |
Life Technologies Corporation |
Transfection reagents
|
|
GB9902000D0
(en)
|
1999-01-30 |
1999-03-17 |
Delta Biotechnology Ltd |
Process
|
|
US7390780B2
(en)
|
1999-04-23 |
2008-06-24 |
Alza Corporation |
Gene delivery mediated by liposome-DNA complex with cleavable peg surface modification
|
|
WO2000074763A2
(en)
|
1999-06-04 |
2000-12-14 |
Georgia Tech Research Corporation |
Devices and methods for enhanced microneedle penetration of biological barriers
|
|
US20110171185A1
(en)
|
1999-06-30 |
2011-07-14 |
Klimanskaya Irina V |
Genetically intact induced pluripotent cells or transdifferentiated cells and methods for the production thereof
|
|
US20020054895A1
(en)
|
1999-07-23 |
2002-05-09 |
Alwyn Company, Inc. |
Allantoin-containing skin cream
|
|
US6595947B1
(en)
|
2000-05-22 |
2003-07-22 |
Becton, Dickinson And Company |
Topical delivery of vaccines
|
|
EP2292632A3
(en)
|
2000-09-26 |
2012-07-25 |
Idera Pharmaceuticals, Inc. |
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
|
|
US7189759B2
(en)
|
2001-05-23 |
2007-03-13 |
Medicis Pharmaceutical Corporation |
Compositions for the treatment of pigmentation disorders and methods for their manufacture
|
|
WO2003018767A2
(en)
|
2001-08-27 |
2003-03-06 |
Advanced Cell Technology, Inc. |
Trans-differentiation and re-differentiation of somatic cells and production of cells for cell therapies
|
|
WO2003027277A1
(en)
|
2001-09-21 |
2003-04-03 |
Japan Science And Technology Corporation |
Method of screening reporgramming factor, reprogramming factor screened by the method, method of using the reprogramming factor, method of differentiating undifferentiated fused cells and method of constructing cell, tissues and organs
|
|
US20050053588A1
(en)
|
2001-10-18 |
2005-03-10 |
Li Yin |
Conversion of liver stem and progenitor cells to pancreatic functional cells
|
|
US7276489B2
(en)
|
2002-10-24 |
2007-10-02 |
Idera Pharmaceuticals, Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
|
|
GB0202149D0
(en)
|
2002-01-30 |
2002-03-20 |
Univ Edinburgh |
Pluripotency determining factors and uses thereof
|
|
US20030186249A1
(en)
|
2002-04-01 |
2003-10-02 |
Zairen Sun |
Human TARPP genes and polypeptides
|
|
JP3785508B2
(ja)
|
2002-04-15 |
2006-06-14 |
学校法人慶應義塾 |
遺伝子治療における免疫応答を解析できる実験モデルマウス
|
|
DE10234192B4
(de)
|
2002-07-26 |
2009-11-26 |
Epoplus Gmbh Co.Kg |
Verwendung von Erythropoetin
|
|
US7737182B2
(en)
|
2002-08-09 |
2010-06-15 |
Taisho Pharmaceutical Co., Ltd. |
Pharmaceuticals for xerosis
|
|
JP4579911B2
(ja)
|
2003-06-03 |
2010-11-10 |
アイシス・ファーマシューティカルズ・インコーポレイテッド |
スルビビン発現の調節
|
|
US7682828B2
(en)
|
2003-11-26 |
2010-03-23 |
Whitehead Institute For Biomedical Research |
Methods for reprogramming somatic cells
|
|
BRPI0514641A
(pt)
|
2004-09-08 |
2008-06-17 |
Wisconsin Alumni Res Found |
cultivação das células tronco embriÈnica humana
|
|
BRPI0514778B1
(pt)
|
2004-09-08 |
2018-07-10 |
Wisconsin Alumni Research Foundation |
Meio para cultivar células tronco embrionárias
|
|
WO2006047728A2
(en)
|
2004-10-27 |
2006-05-04 |
New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery |
Bmp gene and fusion protein
|
|
CA2595695A1
(en)
|
2005-01-25 |
2006-08-03 |
Cell Therapeutics, Inc. |
Biologically active protein conjugates comprising (nn[s/t]) peptide repeats and having increased plasma half-life
|
|
JP5147692B2
(ja)
|
2005-07-13 |
2013-02-20 |
ノボ ノルディスク ヘルス ケア アーゲー |
治療用タンパク質生成のための宿主細胞タンパク質ノックアウト細胞
|
|
EP1913149A4
(en)
|
2005-07-26 |
2009-08-05 |
Sangamo Biosciences Inc |
TARGETED INTEGRATION AND EXPRESSION OF EXOGENOUS NUCLEIC ACID SEQUENCES
|
|
US8323666B2
(en)
|
2005-08-01 |
2012-12-04 |
Allergan, Inc. |
Botulinum toxin compositions
|
|
US9012219B2
(en)
|
2005-08-23 |
2015-04-21 |
The Trustees Of The University Of Pennsylvania |
RNA preparations comprising purified modified RNA for reprogramming cells
|
|
PL2578685T3
(pl)
|
2005-08-23 |
2020-01-31 |
The Trustees Of The University Of Pennsylvania |
Rna zawierający zmodyfikowane nukleozydy i sposoby jego zastosowania
|
|
WO2007026353A2
(en)
|
2005-08-29 |
2007-03-08 |
Technion Research & Development Foundation Ltd. |
Media for culturing stem cells
|
|
TW200732347A
(en)
|
2005-10-06 |
2007-09-01 |
Trophogen Inc |
VEGF analogs and methods of use
|
|
EP2206724A1
(en)
|
2005-12-13 |
2010-07-14 |
Kyoto University |
Nuclear reprogramming factor
|
|
US8278104B2
(en)
|
2005-12-13 |
2012-10-02 |
Kyoto University |
Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
|
|
US8129187B2
(en)
|
2005-12-13 |
2012-03-06 |
Kyoto University |
Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2
|
|
WO2007079886A1
(de)
|
2005-12-22 |
2007-07-19 |
Csl Behring Gmbh |
Oktanoatreduziertes human albumin
|
|
US7658728B2
(en)
|
2006-01-10 |
2010-02-09 |
Yuzhakov Vadim V |
Microneedle array, patch, and applicator for transdermal drug delivery
|
|
DE102006051516A1
(de)
|
2006-10-31 |
2008-05-08 |
Curevac Gmbh |
(Basen-)modifizierte RNA zur Expressionssteigerung eines Proteins
|
|
GB0623635D0
(en)
|
2006-11-27 |
2007-01-03 |
Stem Cell Sciences Uk Ltd |
Pluripotent cell growth media
|
|
US7785301B2
(en)
|
2006-11-28 |
2010-08-31 |
Vadim V Yuzhakov |
Tissue conforming microneedle array and patch for transdermal drug delivery or biological fluid collection
|
|
WO2008073856A2
(en)
|
2006-12-08 |
2008-06-19 |
Massachusetts Institute Of Technology |
Delivery of nanoparticles and/or agents to cells
|
|
CN101200758A
(zh)
|
2006-12-15 |
2008-06-18 |
华中科技大学 |
一种检测col7a1基因突变的方法及其用途
|
|
US10829733B2
(en)
|
2007-01-04 |
2020-11-10 |
Biolamina Ab |
Composition and method for enabling proliferation of pluripotent human stem cells
|
|
US20100172882A1
(en)
|
2007-01-11 |
2010-07-08 |
Glazer Peter M |
Compositions and methods for targeted inactivation of hiv cell surface receptors
|
|
US9249423B2
(en)
|
2007-02-02 |
2016-02-02 |
Yale University |
Method of de-differentiating and re-differentiating somatic cells using RNA
|
|
WO2008097926A2
(en)
|
2007-02-02 |
2008-08-14 |
Yale University |
Transient transfection with rna
|
|
DK3399025T3
(da)
|
2007-03-23 |
2025-06-16 |
Wisconsin Alumni Res Found |
Omprogrammering af somatiske celler
|
|
MX348010B
(es)
|
2007-04-07 |
2017-05-23 |
Whitehead Inst Biomedical Res |
Reprogramacion de celulas somaticas.
|
|
WO2008151845A2
(en)
*
|
2007-06-15 |
2008-12-18 |
Charite - Universitätsmedizin Berlin |
Methods for producing glycosylated human alpha-1 antitrypsin (a1at) in mammalian host cells
|
|
JP2008307007A
(ja)
|
2007-06-15 |
2008-12-25 |
Bayer Schering Pharma Ag |
出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
|
|
KR101532442B1
(ko)
|
2007-12-10 |
2015-06-29 |
고쿠리츠 다이가쿠 호진 교토 다이가쿠 |
효율적인 핵 초기화 방법
|
|
EP2072618A1
(en)
|
2007-12-14 |
2009-06-24 |
Johannes Gutenberg-Universität Mainz |
Use of RNA for reprogramming somatic cells
|
|
BRPI0820762A2
(pt)
|
2007-12-14 |
2015-06-16 |
Dsm Ip Assests Bv |
Processo sol-gel com uma catalisador protegido
|
|
EP2222696A1
(en)
|
2007-12-21 |
2010-09-01 |
Stryker Corporation |
Bmp mutants with decreased susceptibility to noggin
|
|
JP5951254B2
(ja)
|
2008-03-17 |
2016-07-13 |
ザ スクリプス リサーチ インスティテュート |
人工多能性幹細胞を作製するための化学的手法と遺伝的手法の組み合わせ法
|
|
US20110045001A1
(en)
|
2008-03-28 |
2011-02-24 |
Biontex Laboratories Gmbh |
Transfection results of non-viral gene delivery systems by influencing of the innate immune system
|
|
WO2009127230A1
(en)
|
2008-04-16 |
2009-10-22 |
Curevac Gmbh |
MODIFIED (m)RNA FOR SUPPRESSING OR AVOIDING AN IMMUNOSTIMULATORY RESPONSE AND IMMUNOSUPPRESSIVE COMPOSITION
|
|
JP2011160661A
(ja)
|
2008-06-02 |
2011-08-25 |
Kyowa Hakko Kirin Co Ltd |
血球細胞の初期化法
|
|
ES2587395T3
(es)
|
2008-06-04 |
2016-10-24 |
Cellular Dynamics International, Inc. |
Procedimientos para la producción de células IPS usando un enfoque no vírico
|
|
WO2009147400A1
(en)
|
2008-06-05 |
2009-12-10 |
Iti Scotland Limited |
Stem cell culture media and methods
|
|
WO2010008486A2
(en)
|
2008-06-24 |
2010-01-21 |
Parkinsons Institute |
Pluripotent cell lines and methods of use thereof
|
|
US20100184033A1
(en)
|
2008-07-16 |
2010-07-22 |
West Michael D |
Methods to accelerate the isolation of novel cell strains from pluripotent stem cells and cells obtained thereby
|
|
EP2151248A1
(en)
|
2008-07-30 |
2010-02-10 |
Johann Bauer |
Improved pre-mRNA trans-splicing molecule (RTM) molecules and their uses
|
|
EP2326711A2
(en)
|
2008-08-20 |
2011-06-01 |
VIRxSYS Corporation |
Compositions and methods for generation of pluripotent stem cells
|
|
US20100076057A1
(en)
|
2008-09-23 |
2010-03-25 |
Northwestern University |
TARGET DNA INTERFERENCE WITH crRNA
|
|
EP3450545B1
(en)
|
2008-10-24 |
2023-08-23 |
Wisconsin Alumni Research Foundation |
Pluripotent stem cells obtained by non-viral reprogramming
|
|
KR20160150109A
(ko)
|
2008-11-18 |
2016-12-28 |
쓰리엠 이노베이티브 프로퍼티즈 컴파니 |
중공 마이크로니들 어레이
|
|
EP2881461A1
(en)
|
2008-11-21 |
2015-06-10 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Reprogramming cells toward a pluripotent state
|
|
EP2206723A1
(en)
|
2009-01-12 |
2010-07-14 |
Bonas, Ulla |
Modular DNA-binding domains
|
|
US20110239315A1
(en)
|
2009-01-12 |
2011-09-29 |
Ulla Bonas |
Modular dna-binding domains and methods of use
|
|
EP2412800A1
(en)
|
2010-07-29 |
2012-02-01 |
Koninklijke Nederlandse Akademie van Wetenschappen |
Liver organoid, uses thereof and culture method for obtaining them
|
|
US20100209404A1
(en)
|
2009-02-10 |
2010-08-19 |
University Of Dayton |
Enhanced method for producing stem-like cells from somatic cells
|
|
US10894944B2
(en)
|
2009-04-10 |
2021-01-19 |
Monash University |
Cell culture media
|
|
WO2010123501A1
(en)
|
2009-04-22 |
2010-10-28 |
Massachusetts Institute Of Technology |
Innate immune suppression enables repeated delivery of long rna molecules
|
|
US10837020B2
(en)
|
2009-04-22 |
2020-11-17 |
Massachusetts Institute Of Technology |
Innate immune suppression enables repeated delivery of long RNA molecules
|
|
ES2849181T3
(es)
|
2009-04-22 |
2021-08-16 |
Viacyte Inc |
Composiciones celulares derivadas de células reprogramadas desdiferenciadas
|
|
EP2251437B1
(en)
|
2009-05-13 |
2013-12-04 |
Hannelore Breitenbach-Koller |
Method for identifying compounds that control the translational activity of ribosomal proteins in differential mRNA expression
|
|
US8496941B2
(en)
|
2009-06-03 |
2013-07-30 |
National Institute Of Advanced Industrial Science And Technology |
Vectors for generating pluripotent stem cells and methods of producing pluripotent stem cells using the same
|
|
WO2010148050A2
(en)
|
2009-06-16 |
2010-12-23 |
Curna, Inc. |
Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene
|
|
EA022786B1
(ru)
|
2009-07-31 |
2016-03-31 |
Этрис Гмбх |
Рнк с комбинацией из немодифицированных и модифицированных нуклеотидов для экспрессии белков
|
|
KR101775926B1
(ko)
|
2009-11-04 |
2017-09-07 |
셀룰러 다이내믹스 인터내셔널, 인코포레이티드 |
화학 물질을 이용한 에피솜 재프로그래밍
|
|
EP2499239A1
(en)
|
2009-11-11 |
2012-09-19 |
Sanford-Burnham Medical Research Institute |
METHOD FOR GENERATION AND REGULATION OF iPS CELLS AND COMPOSITIONS THEREOF
|
|
ES2769129T3
(es)
|
2009-12-07 |
2020-06-24 |
Univ Pennsylvania |
Preparaciones de ARN que comprenden ARN modificado purificado para reprogramar células
|
|
US20130189741A1
(en)
|
2009-12-07 |
2013-07-25 |
Cellscript, Inc. |
Compositions and methods for reprogramming mammalian cells
|
|
PT2816112T
(pt)
|
2009-12-10 |
2018-11-20 |
Univ Iowa State Res Found Inc |
Modificação do adn modificada pelo efector tal
|
|
US8557972B2
(en)
|
2009-12-21 |
2013-10-15 |
University Of Washington Through Its Center For Commercialization |
Compositions and methods for transfection of RNA and controlled stabilization of transfected RNA
|
|
WO2011094738A1
(en)
|
2010-02-01 |
2011-08-04 |
The Board Of Trustees Of The Leland Stanford Junior University |
Enhanced efficiency of induced pluripotent stem cell generation
|
|
US20140194482A1
(en)
|
2010-02-02 |
2014-07-10 |
Scioderm, Inc. |
Compositions and methods of treatment of inflammatory skin conditions using allantoin
|
|
WO2011102532A1
(ja)
|
2010-02-16 |
2011-08-25 |
国立大学法人九州大学 |
誘導肝細胞
|
|
WO2011110886A1
(en)
|
2010-03-09 |
2011-09-15 |
Biolamina Ab |
Composition and method for enabling proliferation of pluripotent human stem cells
|
|
WO2011130624A2
(en)
|
2010-04-16 |
2011-10-20 |
Immune Disease Institute, Inc. |
Sustained polypeptide expression from synthetic, modified rnas and uses thereof
|
|
CN102234627B
(zh)
|
2010-04-30 |
2015-06-03 |
中国科学院广州生物医药与健康研究院 |
一种培养基添加剂及其应用
|
|
US9725695B2
(en)
|
2010-05-05 |
2017-08-08 |
The Regents Of The University Of California |
Stem cell defined media for xeno-free and feeder free conditions and uses thereof
|
|
US8048675B1
(en)
|
2010-05-12 |
2011-11-01 |
Ipierian, Inc. |
Integration-free human induced pluripotent stem cells from blood
|
|
EP2569424A1
(en)
|
2010-05-12 |
2013-03-20 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the dystrophin gene and uses thereof
|
|
AU2011256838B2
(en)
|
2010-05-17 |
2014-10-09 |
Sangamo Therapeutics, Inc. |
Novel DNA-binding proteins and uses thereof
|
|
EP2392208B1
(en)
|
2010-06-07 |
2016-05-04 |
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Fusion proteins comprising a DNA-binding domain of a Tal effector protein and a non-specific cleavage domain of a restriction nuclease and their use
|
|
WO2011159369A1
(en)
|
2010-06-14 |
2011-12-22 |
Iowa State University Research Foundation, Inc. |
Nuclease activity of tal effector and foki fusion protein
|
|
CN108531444A
(zh)
|
2010-08-05 |
2018-09-14 |
威斯康星校友研究基金会 |
用于人多能细胞培养的简化基础培养基
|
|
CA2807552A1
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
US20140127814A1
(en)
|
2010-08-10 |
2014-05-08 |
Srinivasan Chandrasegaran |
Generation and use of pluripotent stem cells
|
|
GB201014169D0
(en)
*
|
2010-08-25 |
2010-10-06 |
Cambridge Entpr Ltd |
In vitro hepatic differentiation
|
|
US9447408B2
(en)
|
2010-09-14 |
2016-09-20 |
Kyoto University |
Method of efficiently establishing induced pluripotent stem cells
|
|
EP2857499A1
(en)
|
2010-10-01 |
2015-04-08 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
EP2625278A1
(en)
|
2010-10-08 |
2013-08-14 |
Regents of the University of Minnesota |
A method to increase gene targeting frequency
|
|
WO2012060473A1
(en)
|
2010-11-04 |
2012-05-10 |
Kyoto University |
Method of efficiently establishing induced pluripotent stem cells
|
|
WO2012094132A1
(en)
|
2011-01-05 |
2012-07-12 |
Sangamo Biosciences, Inc. |
Methods and compositions for gene correction
|
|
AU2012225497A1
(en)
|
2011-03-07 |
2013-10-24 |
Massachusetts Institute Of Technology |
Methods for transfecting cells with nucleic acids
|
|
WO2012131090A1
(en)
|
2011-03-31 |
2012-10-04 |
Galderma Research & Development |
Method for treatment of xeroderma pigmentosum
|
|
CA2831613A1
(en)
|
2011-03-31 |
2012-10-04 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
|
US10086043B2
(en)
|
2011-04-03 |
2018-10-02 |
The General Hospital Corporation |
Efficient protein expression in vivo using modified RNA (MOD-RNA)
|
|
US20140115726A1
(en)
|
2011-04-05 |
2014-04-24 |
Cellectis |
New tale-protein scaffolds and uses thereof
|
|
CA2834375C
(en)
*
|
2011-04-27 |
2020-07-14 |
Amyris, Inc. |
Methods for genomic modification
|
|
WO2012174224A2
(en)
|
2011-06-17 |
2012-12-20 |
Calando Pharmaceuticals, Inc. |
Methods for administering nucleic acid-based therapeutics
|
|
WO2012176015A1
(en)
|
2011-06-24 |
2012-12-27 |
Leo Pharma A/S |
Methods for treating uv-damaged skin and scc tumors and for removing tattoos with topical ingenol mebutate
|
|
US9862926B2
(en)
|
2011-06-27 |
2018-01-09 |
Cellscript, Llc. |
Inhibition of innate immune response
|
|
WO2013009825A1
(en)
|
2011-07-11 |
2013-01-17 |
Cellular Dynamics International, Inc. |
Methods for cell reprogramming and genome engineering
|
|
CN103842517A
(zh)
|
2011-08-03 |
2014-06-04 |
莲花组织修复公司 |
胶原蛋白7及相关方法
|
|
EP2758529B1
(en)
*
|
2011-09-21 |
2019-03-20 |
Sangamo Therapeutics, Inc. |
Methods and compositions for regulation of transgene expression
|
|
PT3682905T
(pt)
|
2011-10-03 |
2022-04-07 |
Modernatx Inc |
Nucleósidos, nucleótidos e ácidos nucleicos modificados e respetivas utilizações
|
|
EP2766480B1
(en)
|
2011-10-11 |
2018-03-14 |
INSERM - Institut National de la Santé et de la Recherche Médicale |
Exon skipping therapy for dystrophic epidermolysis bullosa
|
|
BR112014008694A2
(pt)
|
2011-10-11 |
2017-06-20 |
Novartis Ag |
moléculas de ácido nucleico policistrônico recombinante
|
|
WO2013078199A2
(en)
|
2011-11-23 |
2013-05-30 |
Children's Medical Center Corporation |
Methods for enhanced in vivo delivery of synthetic, modified rnas
|
|
EP3260140B1
(en)
|
2011-12-05 |
2021-02-03 |
Factor Bioscience Inc. |
Methods and products for transfecting cells
|
|
US8497124B2
(en)
|
2011-12-05 |
2013-07-30 |
Factor Bioscience Inc. |
Methods and products for reprogramming cells to a less differentiated state
|
|
EP2791159A4
(en)
|
2011-12-14 |
2015-10-14 |
Moderna Therapeutics Inc |
MODIFIED NUCLEIC ACIDS AND ACUTE TREATMENT USES THEREOF
|
|
ES2923757T3
(es)
|
2011-12-16 |
2022-09-30 |
Modernatx Inc |
Composiciones de ARNm modificado
|
|
AU2012358384A1
(en)
|
2011-12-21 |
2014-07-31 |
Moderna Therapeutics, Inc. |
Methods of increasing the viability or longevity of an organ or organ explant
|
|
DK3421601T3
(da)
|
2011-12-30 |
2020-02-24 |
Cellscript Llc |
Fremstilling og anvendelse af in-vitro-syntetiseret ssRNA til indføring i pattedyrceller med henblik på at inducere en biologisk eller biokemisk effekt
|
|
WO2013151664A1
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins
|
|
US9340784B2
(en)
*
|
2012-03-19 |
2016-05-17 |
Ionis Pharmaceuticals, Inc. |
Methods and compositions for modulating alpha-1-antitrypsin expression
|
|
WO2013152220A2
(en)
|
2012-04-04 |
2013-10-10 |
Life Technologies Corporation |
Tal-effector assembly platform, customized services, kits and assays
|
|
US20150211004A1
(en)
|
2012-04-20 |
2015-07-30 |
Agency For Science, Technology And Research |
Rnai-based therapies for cardiomyopathies, muscular dystrophies and laminopathies
|
|
AU2013251649B2
(en)
|
2012-04-24 |
2019-04-04 |
Vcell Therapeutics, Inc. |
Generating pluripotent cells de novo
|
|
US10155929B2
(en)
|
2012-05-13 |
2018-12-18 |
Allele Biotechnology & Pharmaceuticals, Inc. |
Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger RNA
|
|
CN104520424B
(zh)
|
2012-05-13 |
2019-06-28 |
美国绿阳生物技术及医药公司 |
使用合成的信使rna无饲养细胞地衍生人类诱导性多能干细胞
|
|
US10119150B2
(en)
|
2012-05-13 |
2018-11-06 |
Allele Biotechnology & Pharmaceuticals, Inc. |
Feeder-free Derivation of human-induced pluripotent stem cells with synthetic messenger RNA
|
|
WO2014015314A1
(en)
|
2012-07-19 |
2014-01-23 |
University Of Southern California |
Recombinant c7 and methods of use
|
|
WO2014059173A2
(en)
*
|
2012-10-10 |
2014-04-17 |
Sangamo Biosciences, Inc. |
T cell modifying compounds and uses thereof
|
|
CA2890110C
(en)
*
|
2012-11-01 |
2023-05-02 |
Factor Bioscience Inc. |
Methods and products for expressing proteins in cells
|
|
CN105229144A
(zh)
|
2013-02-22 |
2016-01-06 |
细胞动力学国际有限公司 |
通过组合的遗传工程和化学工程经由正向编程产生肝细胞
|
|
SG11201506052PA
(en)
*
|
2013-02-22 |
2015-09-29 |
Curevac Gmbh |
Combination of vaccination and inhibition of the pd-1 pathway
|
|
US10525075B2
(en)
|
2013-02-22 |
2020-01-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compounds, compositions, methods, and kits relating to telomere extension
|
|
WO2014134412A1
(en)
|
2013-03-01 |
2014-09-04 |
Regents Of The University Of Minnesota |
Talen-based gene correction
|
|
JP6738728B2
(ja)
*
|
2013-06-17 |
2020-08-19 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
肝臓ターゲティングおよび治療のためのＣＲＩＳＰＲ−Ｃａｓ系、ベクターおよび組成物の送達および使用
|
|
CA2916499A1
(en)
|
2013-07-03 |
2015-01-08 |
Dicerna Pharmaceuticals, Inc. |
Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded rna
|
|
US20160220613A1
(en)
|
2013-09-16 |
2016-08-04 |
Agency For Science, Technology And Research |
Method
|
|
US20150166984A1
(en)
*
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting alpha-antitrypsin point mutations
|
|
CN113105559A
(zh)
|
2013-12-12 |
2021-07-13 |
生命技术公司 |
增强转染的膜穿透性肽和组合物以及其使用方法
|
|
US20150167017A1
(en)
|
2013-12-13 |
2015-06-18 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
|
KR102415811B1
(ko)
*
|
2014-01-31 |
2022-07-04 |
팩터 바이오사이언스 인크. |
핵산 제조 및 송달을 위한 방법 및 산물
|
|
DK3105317T3
(en)
*
|
2014-02-14 |
2019-01-14 |
Cellectis |
Immunotherapy cells that are genetically engineered to target antigen on both immune cells and pathological cells
|
|
SG11201608701QA
(en)
*
|
2014-04-18 |
2016-11-29 |
Editas Medicine Inc |
Crispr-cas-related methods, compositions and components for cancer immunotherapy
|
|
HRP20220070T1
(hr)
*
|
2014-04-23 |
2022-04-01 |
Modernatx, Inc. |
Cjepiva nukleinske kiseline
|
|
KR102546296B1
(ko)
*
|
2014-10-31 |
2023-06-21 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
변형된 t 세포에서 유전자 발현의 변경 및 그의 용도
|
|
RU2751362C2
(ru)
*
|
2014-12-29 |
2021-07-13 |
Новартис Аг |
Способы получения экспрессирующих химерный антигенный рецептор клеток
|
|
US11241505B2
(en)
|
2015-02-13 |
2022-02-08 |
Factor Bioscience Inc. |
Nucleic acid products and methods of administration thereof
|
|
WO2017093804A2
(en)
*
|
2015-12-01 |
2017-06-08 |
Crispr Therapeutics Ag |
Materials and methods for treatment of alpha-1 antitrypsin deficiency
|
|
MX2018010484A
(es)
*
|
2016-03-04 |
2019-01-10 |
Editas Medicine Inc |
Métodos, composiciones y componentes relacionados con crispr-cpf1 para la inmunoterapia contra el cáncer.
|
|
EP3433364A1
(en)
*
|
2016-03-25 |
2019-01-30 |
Editas Medicine, Inc. |
Systems and methods for treating alpha 1-antitrypsin (a1at) deficiency
|
|
KR102614675B1
(ko)
*
|
2016-04-15 |
2023-12-19 |
메모리얼 슬로안 케터링 캔서 센터 |
유전자이식 t 세포 및 키메라 항원 수용체 t 세포 조성물 및 관련 방법
|
|
IL264439B2
(en)
*
|
2016-08-17 |
2024-08-01 |
Factor Bioscience Inc |
non-viral, cell-free composition comprising a synthetic messenger RNA (MRNA) encoding a gene-editing protein for use in treating cancer, and a synthetic RNA encoding a gene-editing protein for use in treatment
|